NCT02223637View on ClinicalTrials.gov

Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry

CompletedOBSERVATIONAL
Enrollment

93

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 8, 2017

Study Completion Date

December 8, 2017

Conditions
Meningococcal DiseasePregnancyInfections, Meningococcal
Interventions
BIOLOGICAL

Meningococcal quadrivalent CRM-197 conjugate vaccine

This pregnancy registry is strictly observational. Decisions of vaccination are made by health care providers.

Trial Locations (2)

28401-3331

GSK Investigational Site, Wilmington

28401-

GSK Investigational Site, Wilmington

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry | Biotech Hunter | Biotech Hunter